✦ LIBER ✦

Clinical and biomarker endpoint analysis in neoadjuvant endocrine therapy trials

✍ Scribed by Yu Tao; Andreas Klause; Andrew Vickers; Kyongtae Bae; Matthew Ellis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biomarkers and surrogate endpoints in cl

✍ Thomas R. Fleming; John H. Powers 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 492 KB

Aromatase expression and outcomes in the

✍ Matthew J. Ellis; William R. Miller; Yu Tao; Dean B. Evans; Hilary A. Chaudri Ro 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 283 KB

A common language in neoadjuvant breast

✍ Debora Fumagalli; Philippe L Bedard; Zeina Nahleh; Stefan Michiels; Christos Sot 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 144 KB

Endpoints, patient selection, and biomar

✍ Marijo Bilusic; James L. Gulley 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 265 KB

Biochemical biomarkers as endpoints in c

✍ Eric Siemers 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Biomarkers and Surrogate Endpoints in Re

✍ Peter A. Lachenbruch; Amy S. Rosenberg; Ezio Bonvini; Marc W. Cavaillé-Coll; Rob 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB